PUBLICATION
Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug
- Authors
- Zhong, J., Xiao, C., Chen, Q., Pan, X., Xu, T., Wang, Y., Hou, W., Liu, L., Cao, F., Wang, Y., Li, X., Zhou, L., Yang, H., Yang, Y., Zhao, C.
- ID
- ZDB-PUB-230908-66
- Date
- 2023
- Source
- iScience 26: 107734107734 (Journal)
- Registered Authors
- Keywords
- Biological sciences, Cell biology, Molecular biology
- MeSH Terms
- none
- PubMed
- 37680473 Full text @ iScience
Abstract
Tumor vasculature often exhibits disorder and inefficiency. Vascular normalization offers potential for alleviating hypoxia and optimizing drug delivery in tumors. However, identifying effective agents is hindered by a lack of robust screening. We aimed to establish a comprehensive method using the zebrafish functional xenograft vasculature platform (zFXVP) to visualize and quantify tumor vasculature changes. Employing zFXVP, we systematically screened compounds, identifying PF-502 as a robust vascular normalization agent. Mechanistic studies showed PF-502 induces endothelial cell-cycle arrest, streamlines vasculature, and activates Notch1 signaling, enhancing stability and hemodynamics. In murine models, PF-502 exhibited pronounced vascular normalization and improved drug delivery at a sub-maximum tolerated dose. These findings highlight zFXVP's utility and suggest PF-502 as a promising adjunctive for vascular normalization in clinical settings.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping